HCA Healthcare, Inc. $HCA Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,663,705 shares of the company’s stock after acquiring an additional 13,565 shares during the period. Geode Capital Management LLC’s holdings in HCA Healthcare were worth $1,702,738,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Life Cycle Investment Partners Ltd acquired a new stake in HCA Healthcare during the fourth quarter worth about $374,037,000. Viking Global Investors LP grew its holdings in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after acquiring an additional 649,058 shares during the period. Danske Bank A S purchased a new stake in HCA Healthcare during the third quarter worth $115,530,000. Finally, Zurich Insurance Group Ltd FI boosted its holdings in HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after buying an additional 262,912 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 2.1%

HCA stock opened at $384.01 on Friday. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market cap of $85.19 billion, a price-to-earnings ratio of 13.21, a PEG ratio of 1.24 and a beta of 1.18. The business’s 50-day moving average is $454.43 and its 200 day moving average is $481.46.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the firm posted $6.45 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCA. Robert W. Baird lowered their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Truist Financial lowered their price target on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Royal Bank Of Canada lowered their price target on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, KeyCorp decreased their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.